NCT00290134View on ClinicalTrials.gov

A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

October 31, 2007

Conditions
Hypogonadism
Interventions
DRUG

Fispemifene once daily for 4 weeks

Trial Locations (16)

11530

Clinical Research Site, Garden City

12601

Clinical Research Site, Poughkeepsie

14221

Clinical Research Site, Williamsville

20770

Clinical Research Site, Greenbelt

29650

Clinical Research Site, Greer

32308

Clinical Research Site, Tallahassee

34652

Clinical Research Site, New Port Richey

35801

Clinical Research Site, Huntsville

61614

Clinical Research Site, Peoria

73008

Clinical Research Site, Bethany

78229

Clinical Research Site, San Antonio

80012

Clinical Research Site, Aurora

89109

Clinical Research Site, Las Vegas

95350

Clinical Research Site, Modesto

98166

Clinical Research Site, Seattle

06708

Clinical Research Site, Waterbury

Sponsors

Collaborators (1)

Hormos Medical
All Listed Sponsors
collaborator

Hormos Medical

INDUSTRY

lead

QuatRx Pharmaceuticals Company

INDUSTRY